You may have heard that a glass of red wine a day is good for your heart. Research now shows that the beneficial compound found in red wine may also help fight prostate cancer.

For men with aggressive prostate cancer, few treatment options are available. A new drug, however, showed a positive effect in reducing the number of tumor cells and cancer markers in advanced prostate cancer.

Prostate cancer is the most common non-skin cancer in men. While some specialty organizations recommend that screening begin at age 40, there is little evidence showing real benefits to screening at this age.

After prostate cancer patients receive treatment, they still run the risk of the disease coming back. A newly approved imaging agent offers a way to detect recurrence earlier.

Prostate cancer surgery patients commonly experience erectile dysfunction. While many seek therapy to regain function, they may need more partner support to stay with the program.

Although most men who have their prostate removed to treat prostate cancer stay disease free, some have a recurrence. Radiation following the surgery appears to reduce the chance of the cancer returning.

To determine treatment for prostate cancer, doctors may look to a patient’s DNA. How aggressive the disease will be may be predicted by examining gene patterns in blood cells.

For 23 years, the third week in September has been designated “Prostate Cancer Awareness Week.” That’s when the Prostate Conditions Education Council ( PCEC ) was founded to give men access to free or low-cost prostate health screenings.